A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A Prospective, RanDomized, Multi-Center, Open-Label, Cross-Over Study of Sodium Zirconium
Cyclosilicate to Control Interdialytic HyperkalemiA Following Augmentation of Dialysate
Potassium: Efficacy to Reduce the Incidence of Post-Dialysis Atrial Fibrillation and
Clinically SignificanT Cardiac Arrhythmias - ADAPT Trial